相关实验视频

Updated: Dec 17, 2025

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

具有瘤性成分的恶性类型瘤:一个基因病理学和分子学研究

Ting Lei¹, Yunjie Song², Zhiyi Shen¹

¹Department of Pathology, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu 213003, PR China.

Translational oncology

|February 8, 2025

概括

具有骨髓瘤组件的恶性类型瘤表明预后不佳. 激活TP53突变和NOTCH通路激活驱动瘤进展,建议新的治疗点.

科学领域:

在瘤学瘤学.
基因组学就是基因组学.
病理学病理学病理学

背景情况:

具有瘤性成分的恶性植物瘤 (MPT) 携带高复发风险.
了解它们的分子形状是开发新型治疗策略的关键.

研究的目的:

描述具有瘤成分的MPT的临床病理和分子特征.
为了比较这些特征与MPT缺乏瘤元素的特征.
确定潜在的治疗目标和预后指标.

主要方法:

分析了十个MPT病例,其中八个正在接受下一代测序 (NGS).
具有和没有瘤成分的MPT之间的临床病理学数据和基因组资料的比较.

主要成果:

带有骨髓瘤成分的MPT显示预后明显较差.
在TP53,MUC16,PTCH1和APC基因中观察到高频率的突变.
在MCL1和MYC的放大是频繁的,NOTCH信号通路与瘤性MPT密切相关.

结论:

骨髓瘤组件的存在是MPT中不利的预后指标.
激活TP53突变和NOTCH途径失调与瘤发育和进展有关.
这些发现为临床预后和潜在的治疗干预提供了洞察力.

关键词:

恶性植物瘤瘤瘤.在NOTCH路径上.骨髓肉瘤的组成部分瘤的组成部分是肉瘤.这就是TP53的特点.

更多相关视频

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

相关概念视频

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...